标普生物科技LOF(161127)
动态评分： 6.09分
投资组合
| 报告日期 | 代码 | 名称 | 类型 | 金额(万元) | 占期初比 |
| 2022-12-31 | GBT | 全球血液疗法 | 卖出 | 958.6 | 6.33% |
| 2022-12-31 | TPTX | Turning Point Therapeutics Inc | 卖出 | 668.11 | 4.41% |
| 2022-12-31 | CCXI | ChemoCentryx Inc | 卖出 | 650.56 | 4.29% |
| 2022-12-31 | VERV | Verve Therapeutics Inc | 买入 | 536.71 | 3.54% |
| 2022-12-31 | NVAX | 诺瓦瓦克斯医药 | 买入 | 532.52 | 3.52% |
| 2022-12-31 | TWST | Twist Bioscience Corp | 买入 | 483.03 | 3.19% |
| 2022-12-31 | BLUE | 蓝鸟生物 | 买入 | 452.58 | 2.99% |
| 2022-12-31 | NTLA | Intellia Therapeutics Inc | 买入 | 434.19 | 2.87% |
| 2022-12-31 | MRTX | Mirati Therapeutics Inc | 买入 | 432.84 | 2.86% |
| 2022-12-31 | IOVA | Iovance Biotherapeutics Inc | 买入 | 420.32 | 2.77% |
| 2022-12-31 | KRTX | Karuna Therapeutics Inc | 卖出 | 413.93 | 2.73% |
| 2022-12-31 | BHVN | Biohaven Ltd | 买入 | 410.33 | 2.71% |
| 2022-12-31 | ARNA | Arena Pharmaceuticals Inc | 卖出 | 400.03 | 2.64% |
| 2022-12-31 | CRSP | CRISPR Therapeutics AG | 买入 | 396.51 | 2.62% |
| 2022-12-31 | EDIT | Editas Medicine Inc | 买入 | 392.55 | 2.59% |
| 2022-12-31 | BPMC | Blueprint Medicines Corp | 买入 | 379.43 | 2.5% |
| 2022-12-31 | FATE | Fate Therapeutics Inc | 买入 | 378.28 | 2.5% |
| 2022-12-31 | BEAM | Beam Therapeutics Inc | 买入 | 369.31 | 2.44% |
| 2022-12-31 | NTRA | Natera Inc | 买入 | 368.23 | 2.43% |
| 2022-12-31 | BCRX | BioCryst Pharmaceuticals Inc | 买入 | 358.57 | 2.37% |
公告&资料
